The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

OBJECTIVE: To assess the efficacy and safety of transarterial Chemoembolization (TACE) combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma (HCC). PATIENTS AND METHODS: The data of patients with unresectable HCC administered a combination therapy with TACE and lenvatinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Fei, Yang, Yi, Si, Tongguo, Luo, Jun, Zeng, Hui, Zhang, Zhewei, Feng, Duiping, Chen, Yi, Zheng, Jiaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721033/
https://www.ncbi.nlm.nih.gov/pubmed/34988019
http://dx.doi.org/10.3389/fonc.2021.783480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721033/
https://www.ncbi.nlm.nih.gov/pubmed/34988019
http://dx.doi.org/10.3389/fonc.2021.783480

Ejemplares similares